机译:ABO不相容的异基因造血干细胞移植后纯红细胞发育不全的临床特征和危险因素
Department of Hematology, First Affiliated Hospital of Jinan University, Guangzhou 510630, People's Republic of China;
Department of Hematology, First Affiliated Hospital of Jinan University, Guangzhou 510630, People's Republic of China;
Department of Hematology, First Affiliated Hospital of Jinan University, Guangzhou 510630, People's Republic of China;
Department of Hematology, First Affiliated Hospital of Jinan University, Guangzhou 510630, People's Republic of China;
Department of Hematology, First Affiliated Hospital of Jinan University, Guangzhou 510630, People's Republic of China;
机译:主要ABO不相容异体造血干细胞移植后纯红细胞发育不全的临床特征和危险因素。
机译:抗原特异性免疫吸附糖血管藻含量β? ABO免疫吸附系统作为纯红细胞Allasia的新型治疗方式,术后双向和双向不相容的同种异体造血干细胞移植
机译:抗原特异性免疫吸附与甘草株ABO免疫电容系统,作为纯红细胞APLASIA的新型治疗方式,术后主要和双向的ABO-不相容的同种异体造血干细胞移植
机译:循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
机译:与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
机译:抗原特异性免疫吸附与甘草株ABO免疫电容系统作为纯红细胞APLASIA的新型治疗方式术后主要和双向的ABO-不相容的同种异体造血干细胞移植
机译:延长红细胞Alvasia在主要的Abo-Numpatibal造血干细胞移植后:除去持续的Isohemag凝集蛋白,用IG-Therasorb®Immunoadallinal